Annual FCF
-$182.93 M
-$156.50 M-592.28%
December 31, 2023
Summary
- As of February 7, 2025, BEAM annual free cash flow is -$182.93 million, with the most recent change of -$156.50 million (-592.28%) on December 31, 2023.
- During the last 3 years, BEAM annual FCF has fallen by -$70.83 million (-63.18%).
- BEAM annual FCF is now -592.28% below its all-time high of -$26.42 million, reached on December 31, 2022.
Performance
BEAM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$89.70 M
-$4.73 M-5.57%
September 30, 2024
Summary
- As of February 7, 2025, BEAM quarterly free cash flow is -$89.70 million, with the most recent change of -$4.73 million (-5.57%) on September 30, 2024.
- Over the past year, BEAM quarterly FCF has dropped by -$4.73 million (-5.57%).
- BEAM quarterly FCF is now -142.47% below its all-time high of $211.23 million, reached on March 31, 2022.
Performance
BEAM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$145.37 M
+$8.03 M+5.23%
September 30, 2024
Summary
- As of February 7, 2025, BEAM TTM free cash flow is -$145.37 million, with the most recent change of +$8.03 million (+5.23%) on September 30, 2024.
- Over the past year, BEAM TTM FCF has increased by +$8.03 million (+5.23%).
- BEAM TTM FCF is now -198.09% below its all-time high of $148.21 million, reached on March 31, 2022.
Performance
BEAM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BEAM Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -592.3% | -5.6% | +5.2% |
| 3 y3 years | -63.2% | -3134.8% | -8.5% |
| 5 y5 years | -447.3% | -387.2% | -72.0% |
BEAM Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -592.3% | at low | -142.5% | +22.6% | -198.1% | +62.9% |
| 5 y | 5-year | -592.3% | at low | -142.5% | +22.6% | -198.1% | +62.9% |
| alltime | all time | -592.3% | at low | -142.5% | +22.6% | -198.1% | +62.9% |
Beam Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$89.70 M(+5.6%) | -$145.37 M(-5.2%) |
| Jun 2024 | - | -$84.97 M(-16.8%) | -$153.40 M(-9.4%) |
| Mar 2024 | - | -$102.19 M(-177.7%) | -$169.28 M(-7.5%) |
| Dec 2023 | -$182.93 M(+592.3%) | $131.48 M(-234.5%) | -$182.93 M(-53.3%) |
| Sep 2023 | - | -$97.73 M(-3.1%) | -$391.86 M(+3.0%) |
| Jun 2023 | - | -$100.85 M(-12.9%) | -$380.41 M(+7.6%) |
| Mar 2023 | - | -$115.83 M(+49.6%) | -$353.49 M(+1237.7%) |
| Dec 2022 | -$26.42 M(-76.6%) | -$77.45 M(-10.2%) | -$26.42 M(-166.9%) |
| Sep 2022 | - | -$86.28 M(+16.7%) | $39.49 M(-67.9%) |
| Jun 2022 | - | -$73.92 M(-135.0%) | $123.00 M(-17.0%) |
| Mar 2022 | - | $211.23 M(-1930.6%) | $148.21 M(-231.1%) |
| Dec 2021 | -$113.08 M | -$11.54 M(+316.1%) | -$113.08 M(-15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$2.77 M(-94.3%) | -$133.96 M(-13.7%) |
| Jun 2021 | - | -$48.71 M(-2.7%) | -$155.22 M(+17.8%) |
| Mar 2021 | - | -$50.06 M(+54.4%) | -$131.72 M(+17.5%) |
| Dec 2020 | -$112.10 M(+32.6%) | -$32.42 M(+34.9%) | -$112.10 M(+12.5%) |
| Sep 2020 | - | -$24.03 M(-4.7%) | -$99.64 M(+6.0%) |
| Jun 2020 | - | -$25.20 M(-17.2%) | -$94.01 M(+8.4%) |
| Mar 2020 | - | -$30.44 M(+52.5%) | -$86.75 M(+2.6%) |
| Dec 2019 | -$84.52 M(+152.9%) | -$19.96 M(+8.4%) | -$84.52 M(+30.9%) |
| Sep 2019 | - | -$18.41 M(+2.6%) | -$64.56 M(+39.9%) |
| Jun 2019 | - | -$17.94 M(-36.4%) | -$46.15 M(+63.6%) |
| Mar 2019 | - | -$28.21 M | -$28.21 M |
| Dec 2018 | -$33.42 M | - | - |
FAQ
- What is Beam Therapeutics annual free cash flow?
- What is the all time high annual FCF for Beam Therapeutics?
- What is Beam Therapeutics annual FCF year-on-year change?
- What is Beam Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Beam Therapeutics?
- What is Beam Therapeutics quarterly FCF year-on-year change?
- What is Beam Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Beam Therapeutics?
- What is Beam Therapeutics TTM FCF year-on-year change?
What is Beam Therapeutics annual free cash flow?
The current annual FCF of BEAM is -$182.93 M
What is the all time high annual FCF for Beam Therapeutics?
Beam Therapeutics all-time high annual free cash flow is -$26.42 M
What is Beam Therapeutics annual FCF year-on-year change?
Over the past year, BEAM annual free cash flow has changed by -$156.50 M (-592.28%)
What is Beam Therapeutics quarterly free cash flow?
The current quarterly FCF of BEAM is -$89.70 M
What is the all time high quarterly FCF for Beam Therapeutics?
Beam Therapeutics all-time high quarterly free cash flow is $211.23 M
What is Beam Therapeutics quarterly FCF year-on-year change?
Over the past year, BEAM quarterly free cash flow has changed by -$4.73 M (-5.57%)
What is Beam Therapeutics TTM free cash flow?
The current TTM FCF of BEAM is -$145.37 M
What is the all time high TTM FCF for Beam Therapeutics?
Beam Therapeutics all-time high TTM free cash flow is $148.21 M
What is Beam Therapeutics TTM FCF year-on-year change?
Over the past year, BEAM TTM free cash flow has changed by +$8.03 M (+5.23%)